NCT04792541

Brief Summary

Aim To evaluate the clinical and microbiological effects of a hyaluronan (HY) as adjunct to scaling and root planning of residual pockets during supportive periodontal therapy. Material and Methods Sixty-six chronic periodontitis, that have completed the active phase of treatment and are enrolled in a supportive periodontal therapy scheme, with 4 to 8 interproximal sites with PD ≥ 5 mm \< 8 mm and presence of BoP at the revaluation examination will be randomly assigned to the test (HY containing gel) or control group. Immediately after debridement of the residual pockets the test gel (GUM® Afta Clear Gel, Sunstar) will be applied into the experimental sites by the operator. Further, the participants will be instructed to apply at the experimental sites the test gel supragingivally with an interdental brush (TePe, Malmö, Sweden), once per day after tooth brushing for the first 3 months. Subgingival gel application will be repeated at the 3-month control in persistent pockets (i.e. PD ≥ 5mm + BoP). CAL, PD, BoP, and presence of plaque will be evaluated at baseline and thereafter every 3 months (i.e., after 3, 6, 9, and 12 months). Further, subgingival microbiological samples will be collected from the 4 experimental sites at baseline, 3, 6, and 12 months. Nine periodontal pathogens (Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum, Prevotella intermedia, Parvimonas micra, Campylobacter rectus, Eikenella corrodens), total bacterial load, and amount of Candida albicans will be determined quantitatively by real-time PCR.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
Last Updated

March 15, 2023

Status Verified

March 1, 2023

Enrollment Period

4.2 years

First QC Date

March 8, 2021

Last Update Submit

March 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • residual periodontal pockets

    number of experimental sites showing PD \< 5 mm or no PD ≥ 5 mm + BoP

    12 months

Study Arms (2)

control group

PLACEBO COMPARATOR

saline solution

Other: saline solution

test group

EXPERIMENTAL

HY containing gel; GUM® Afta Clear Gel, Sunstar

Other: HY containing gel; GUM® Afta Clear Gel, Sunstar

Interventions

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of chronic periodontitis
  • at least 10 teeth
  • to 8 interproximal sites with PD ≥ 5 to \< 8 mm and presence of BoP at the revaluation examination
  • no molar with furcation involvement (Class II or III)
  • no difference in PD \> 2 mm next to the experimental site

You may not qualify if:

  • antibiotic therapy or active periodontal treatment in the previous 6 months
  • long-term use of anti-inflammatory and immunosuppressive medication
  • diabetes
  • pregnancy or lactatio
  • need for antibiotics prophylaxis
  • severe occlusal dysfunction
  • orthodontic treatment
  • class II or III tooth mobility
  • endodontic problem

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bertl K, Vlachou S, Pandis N, Zampelis A, Stavropoulos A. Repeated local delivery of hyaluronic acid gel as adjunctive treatment of residual pockets in periodontitis patients undergoing supportive periodontal care. A randomized controlled clinical trial. Clin Oral Investig. 2024 Feb 20;28(2):158. doi: 10.1007/s00784-024-05505-9.

MeSH Terms

Conditions

Periodontitis

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Periodontology

Study Record Dates

First Submitted

March 8, 2021

First Posted

March 11, 2021

Study Start

December 1, 2016

Primary Completion

February 8, 2021

Study Completion

February 8, 2021

Last Updated

March 15, 2023

Record last verified: 2023-03